Active comparator arm for Survivorship

Community Cancer Institute, Clovis, CA
SurvivorshipGeriatric Assessment - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will test whether giving an older cancer survivor a care plan and follow-up visit improves their quality of life.

Treatment Effectiveness

Study Objectives

3 Primary · 4 Secondary · Reporting Duration: 4-6 months

4-6 months
Acceptability of the study: survey
Health related quality of life assessment by QLQ14
Health related quality of life assessment by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire EORTC QLQ-30
Number of months needed for completion of trial enrollment
Patient satisfaction assessment by PSCC (Patient Satisfaction with Cancer related Care) tool
Self rated patient knowledge and preparedness measured by PLANS assessment tool (Preparing for Life as a New Survivor)
Study retention rate

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

No intervention arm
1 of 2
Active comparator arm
1 of 2

Active Control

70 Total Participants · 2 Treatment Groups

Primary Treatment: Active comparator arm · No Placebo Group · N/A

No intervention armNoIntervention Group · 1 Intervention: No intervention arm · Intervention Types:
Active comparator arm
ActiveComparator Group · 1 Intervention: Geriatric Assessment · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4-6 months

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,346 Previous Clinical Trials
11,782,642 Total Patients Enrolled
Haifaa Abdulhaq, MDPrincipal InvestigatorUniversity of California, San Francisco

Eligibility Criteria

Age 65+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the total number of participants enrolled in this investigation?

"Affirmative. According to, this scientific trial is actively recruiting participants; it was initially posted on February 16th 2021 and underwent its most recent update on March 22nd 2022. The research requires 70 individuals from 1 medical facility." - Anonymous Online Contributor

Unverified Answer

What are the chief aims of this trial?

"This medical study is expected to take between 4-6 months, with the primary outcome being completion rates. Secondary objectives include evaluating patient health and quality of life through QLQ-ELD14 that assesses mobility, worries about others, future worries, maintaining purpose and burden of illness alongside two single items (joint stiffness and family support). Additionally, self rated knowledge will be evaluated using PLANS assessment tool which measures survivor satisfaction along a four point scale. Lastly, Patient Satisfaction with Cancer related Care tool (PSCC) will measure participant's level of agreement on five point Likert scales in order to gauge their overall satisfaction." - Anonymous Online Contributor

Unverified Answer

Are investigators still enrolling participants in this research?

"Reports from confirm that this medical trial is currently recruiting patients, with the initial listing posted on February 16th 2021 and last updated on March 22nd 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.